Owkin
Rodrigo Barnes is an accomplished engineering leader with extensive experience in the healthcare and technology sectors. Currently serving as the VP of Engineering at Owkin since September 2022, Rodrigo oversees the development of innovative systems for managed access to medical data to enhance biomedical research and clinical trial optimization. Previously, as Chief Technology Officer at Aridhia from March 2008 to August 2022, Rodrigo contributed to product strategy and agile development for healthcare services. Early career roles include project management and software engineering positions at various organizations, such as Cognia EU Ltd and Axiope Limited, where Rodrigo successfully led R&D projects and built commercial-grade software. Rodrigo's educational background includes a MA (Hons) in Philosophy and Mathematics from The University of Edinburgh.
This person is not in any offices
Owkin
6 followers
Owkin believes that medical research should be collaborative, inclusive, and privacy-preserving. Today, Owkin is pioneering AI in healthcare. It leverages its collaborative federated learning software and expert AI capabilities to bring solutions to optimize drug development and improve patient care in oncology. Owkin’s work has been published in Nature Medicine and other top-tier journals. Owkin has raised over $70M from leading VC funds and is now working with the most prominent cancer centers and pharmaceutical companies in Europe and the US. Additionally, Owkin leads several federated learning consortia, including; MELLODDY, to facilitate 'co-opetive' drug discovery between pharma companies, and Healthchain, to allow collaborative research across multiple hospitals. Owkin was co-founded in 2016 by Thomas Clozel, MD, a clinical research doctor and former assistant professor in clinical hematology, and by Gilles Wainrib, Ph.D., an academic pioneer in the field of Artificial Intelligence in biology.